Methylprednisolone pulse therapy for nonrenal lupus erythematosus.
AUTOR(ES)
Eyanson, S
RESUMO
High-dose intravenous methylprednisolone therapy has previously been shown to be efficacious in the treatment of renal lupus erythematosus. The present report presents 2 patients with life-threatening, nonrenal lupus erythematosus. One patient had coma and seizures, while the other had sever thrombocytopenia and anaemia. Both had failed to respond to oral corticosteroid therapy in high doses but had dramatic clinical responses with intravenous methylprednisolone given in 'pulses.' Possible mechanisms of clinical improvement are discussed.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1000560Documentos Relacionados
- Gastric mucosal injury in systemic lupus erythematosus patients receiving pulse methylprednisolone therapy
- Methyl prednisolone pulse therapy in the treatment of systemic lupus erythematosus.
- Effect of high-dose methylprednisolone therapy on phagocyte function in systemic lupus erythematosus.
- A double blind, placebo controlled trial of intravenous methylprednisolone in systemic lupus erythematosus.
- Pulse methylprednisolone therapy in rheumatoid arthritis.
